Early MS Biomarkers May Improve Prediction of Long-term Outcomes

Serum neurofilament light chain and glial fibrillary acidic protein levels can help improve outcome predictions in multiple sclerosis — and are linked to relapse risk after treatment discontinuation.
Medscape Medical News